Genzyme

Genzyme Corporation is one of the world's most influential biotechnology companies, with a product pipeline that is one of the most comprehensive and significant with investment of £55 million at our Haverhill manufacturing facility, which will increase our capacity ten-fold. This commitment – our largest ever investment outside the USA – will create an international centre for pharmaceutical manufacturing excellence to help meet the ever growing demand for Renagel, a major advance in the treatment of dialysis patients.